NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE118964 Query DataSets for GSE118964
Status Public on Jul 31, 2019
Title Progression of progenitor B cell leukemia is associated with alterations of the bone marrow micro-environment
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Many of the clinical manifestations of B-lymphoid leukemia is a consequence of disrupted formation of normal blood cells. Upon diagnosis. the disease has often progressed into a state with a dramatic dominance of leukemic cells in the BM making it difficult to understand the environmental changes underlying the disruption in blood cell formation. To investigate this process in more detail we have explored pre-clinical stages of leukemia in a mouse model based on transplantation of B-ALL cells from mice trans-heterozygote for mutations in the Ebf1 and Pax5 genes to non-conditioned hosts. This revealed that while the recipient HSC compartment was relatively intact, the presence of erythroid progenitors and in more advanced disease, lymphoid progenitors was reduced. Progression of disease was also reflected in changes of the cellular composition of non hematopoietic compartments as well as changes in gene expression patterns in specific cellular subpopulations. This included increased expression of the cytokine Il7 in the mature stroma cell compartments. The relevance for Il7 in tumor progression was evident from the finding that leukemia development was delayed when tumor cells were transplanted to Il7 deficient mice. Our data suggest that progressive development of B-ALL primarily target the production of normal progenitor cells and that the micro-environment undergo changes that can be predicted to result in a more permissive environment for tumor growth.
 
Overall design For short term transplantations ProB cells were sorted from lymph nodes of sick mice as Lin-CD19+IgM+igD-CD43+Kit+. 100.000 cells were iv-injected to each recipient. Mice were euthanized at indicated time points and organs harvested. As controls, for each experiment setup, four animals were injected with PBS/iFCS. RNA-seq was performed on primary bone marrow and lymph node derived ProB cells from leukemic Pax5+/-Ebf1+/- mice and Wt mice, as well as on non hematopoietic bone marrow stroma cells. Data analysis was performed by alignment to mouse reference genome (mm10 /GRCm38) and mapped with STAR (Dobin et al, Bioinformatics, 2013) followed by analysis by DESeq2 in R.
 
Contributor(s) Åhsberg J, Xiao P, Okuyama K, Somasundaram R, Strid T, Qian H, Sigvardsson M
Citation(s) 31296580
Submission date Aug 23, 2018
Last update date Jul 31, 2019
Contact name Mikael Sigvardsson
E-mail(s) mikael.sigvardsson@liu.se
Organization name Linköping University
Street address Campus US
City Linköping
ZIP/Postal code 58185
Country Sweden
 
Platforms (1)
GPL19057 Illumina NextSeq 500 (Mus musculus)
Samples (67)
GSM3354835 RNAseq_ctrl_CD44_stroma_Day12
GSM3354836 RNAseq_ctrl_CD44_stroma_Day12b
GSM3354837 RNAseq_ctrl_CD44_stroma_Day15
Relations
BioProject PRJNA487544
SRA SRP158678

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE118964_RNASeq_Counts_ProB_CD3.txt.gz 966.7 Kb (ftp)(http) TXT
GSE118964_RNASeq_Counts_Stroma.txt.gz 681.7 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap